Type
Blood Testing
Biomarkers
5
Duration
20 min
A comprehensive sexually transmitted infection screening combining blood-based testing with additional sample methods to provide broader coverage across bacterial, viral, and parasitic STDs. Includes physician review and follow-up consultation.
The Full STD Panel is FirstMed's most thorough sexual health screening option, combining a blood draw with additional sample collection methods to cover a wider range of infections than blood testing alone can detect. While the blood component screens for HIV, hepatitis, and syphilis, the additional elements extend coverage to infections such as chlamydia and gonorrhoea that require different sample types for reliable detection. This panel is recommended for individuals who want comprehensive peace of mind rather than a targeted screen — particularly after potential exposure, at the start of a new relationship, or as part of a regular preventive health routine. The broader sample collection takes slightly longer than the blood-only panel but provides a more complete picture of sexual health status. All testing is conducted in a private, English-speaking clinical environment, and results are reviewed by a physician who provides clear guidance on findings and any recommended next steps. The clinic's central Milan location near the Duomo makes it accessible for both residents and visitors. FirstMed can also coordinate follow-up treatment or specialist referral if any results require further investigation.
Key Details
- Sample types
- Blood + additional
- Coverage
- Comprehensive
- Duration
- ~20 min
- Language
- English
Who Is This For?
Comprehensive STD screening, post-exposure testing, new relationship screening, individuals wanting full coverage beyond blood-only tests
What's Included
Panel Categories
Biomarkers Tested
5Indicates immunity against HBV due to vaccination or previous infection.
Detects antibodies to hepatitis C virus, indicating current or past infection. A positive result requires confirmatory RNA testing. Hepatitis C is now curable with direct-acting antiviral medications in most patients.
Imbalances in gut pH influence short-chain fatty acid production and their effects.
